首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   282篇
  免费   24篇
  2024年   2篇
  2022年   2篇
  2021年   2篇
  2018年   3篇
  2017年   6篇
  2016年   3篇
  2015年   6篇
  2014年   13篇
  2013年   9篇
  2012年   14篇
  2011年   14篇
  2010年   12篇
  2009年   12篇
  2008年   16篇
  2007年   13篇
  2006年   11篇
  2005年   12篇
  2004年   15篇
  2003年   19篇
  2002年   17篇
  2001年   20篇
  2000年   11篇
  1999年   11篇
  1998年   2篇
  1997年   1篇
  1996年   3篇
  1995年   3篇
  1994年   2篇
  1993年   1篇
  1992年   6篇
  1991年   1篇
  1990年   2篇
  1989年   6篇
  1988年   3篇
  1986年   4篇
  1985年   3篇
  1984年   3篇
  1983年   3篇
  1982年   1篇
  1981年   2篇
  1980年   3篇
  1979年   1篇
  1978年   1篇
  1977年   2篇
  1976年   3篇
  1974年   1篇
  1973年   1篇
  1971年   1篇
  1968年   2篇
  1967年   1篇
排序方式: 共有306条查询结果,搜索用时 15 毫秒
231.
232.
233.
The mechanisms by which sex hormones cause changes in body composition are unclear. Sex steroid deficiency might directly reduce energy expenditure/fat oxidation and thereby predispose to increased body fat. Alternatively, sex steroid deficiency could result in lean tissue loss and thus reduced energy expenditure. Our objective was to examine the independent and combined effects of acute testosterone and estrogen withdrawal on respiratory exchange ratio (RER) and resting energy expenditure (REE) in men. The objective of the study was to examine the independent and combined effects of acute estrogen and testosterone withdrawal on RER and REE in men. A total of 54 men aged 50–80 years, BMI range of 17–35 kg/m2 underwent a 3‐week eugonadal run‐in hormone‐treatment period involving suppression of endogenous sex steroids using letrozole and leuprolide acetate (Lupron) while sex steroid concentrations were maintained with transdermal testosterone (T) and estradiol (E). A second Lupron injection was then given and participants were randomized to one of the following four 3‐week treatment groups: group A (?T, ?E), group B (?T, +E), group C (+T, ?E), and group D (+T, +E). REE and RER were measured via indirect calorimetry before and after the 3‐week treatment period. Three‐week suppression and/or repletion of estrogen or testosterone did not produce changes in RER or REE within or between groups. We conclude that abrupt changes in sex steroids does not change resting substrate oxidation, indicating that changes that can be observed after more prolonged periods of deficiency are most likely due to direct effects of sex steroids on body composition.  相似文献   
234.
Transglutaminase 2 (TG2) in the extracellular matrix is largely inactive but is transiently activated upon certain types of inflammation and cell injury. The enzymatic activity of extracellular TG2 thus appears to be tightly regulated. As TG2 is known to be sensitive to changes in the redox environment, inactivation through oxidation presents a plausible mechanism. Using mass spectrometry, we have identified a redox-sensitive cysteine triad consisting of Cys230, Cys370, and Cys371 that is involved in oxidative inactivation of TG2. Within this triad, Cys370 was found to participate in disulfide bonds with both Cys230 and its neighbor, Cys371. Notably, Ca2+ was found to protect against formation of these disulfide bonds. To investigate the role of each cysteine residue, we created alanine mutants and found that Cys230 appears to promote oxidation and inactivation of TG2 by facilitating formation of Cys370–Cys371 through formation of the Cys230–Cys370 disulfide bond. Although vicinal disulfide pairs are found in several transglutaminase isoforms, Cys230 is unique for TG2, suggesting that this residue acts as an isoform-specific redox sensor. Our findings suggest that oxidation is likely to influence the amount of active TG2 present in the extracellular environment.  相似文献   
235.
The female reproductive system plays a major role in regulating the acquisition and loss of bone by the skeleton from menarche through senescence. Onset of gonadal sex steroid secretion at puberty is the major factor responsible for skeletal longitudinal and radial growth, as well as significant gain in bone density, until peak bone density is achieved in third decade of life. Gonadal sex steroids then help maintain peak bone density until menopause, including during the transient changes in skeletal mineral content associated with pregnancy and lactation. At menopause, decreased gonadal sex steroid production normally leads to rapid bone loss. The most rapid bone loss associated with decreased estrogen levels occurs in the first 8-10 years after menopause, with slower age-related bone loss occurring during later life. Age-related bone loss in women after the early menopausal phase of bone loss is caused by ongoing gonadal sex steroid deficiency, vitamin D deficiency, and secondary hyperparathyroidism. Other factors also contribute to age-related bone loss, including intrinsic defects in osteoblast function, impairment of the GH/IGF axis, reduced peak bone mass, age-associated sarcopenia, and various sporadic secondary causes. Further understanding of the relative contributions of the female reproductive system and each of the other factors to development and maintenance of the female skeleton, bone loss, and fracture risk will lead to improved approaches for prevention and treatment of osteoporosis.  相似文献   
236.
Antitumour, antifertility and histopathological investigations were carried out on male rats by the use of organotin complexes. The organotin complexes were synthesized by the alkylation of [Sn(TAML(n))Cl(2)] (n=1-4 and TAML(n) represents the tetraazamacrocyclic ligands) in the presence of CH(3)I or C(2)H(5)Br. The structures of all the complexes have been established on the basis of elemental analyses, conductivity measurements, IR, (1)H NMR, (13)C NMR, (119)Sn NMR and X-ray spectral data. The antitumour effect of the compounds was examined on swiss mice. The results obtained clearly indicated that the compounds, [C(2)H(5)Sn(TAML(3))C(5)H(5)N] and [C(2)H(5)Sn(TAML(4))C(5)H(5)N] display effective antitumour activity. The emphasis has been given on in vivo study on male albino rats (Rattus norvegicus) by performing serum analyses, blood analyses and fertility test.  相似文献   
237.
Biosynthesis of polyketides in heterologous hosts.   总被引:3,自引:0,他引:3  
Polyketide natural products show great promise as medicinal agents. Typically the products of microbial secondary biosynthesis, polyketides are synthesized by an evolutionarily related but architecturally diverse family of multifunctional enzymes called polyketide synthases. A principal limitation for fundamental biochemical studies of these modular megasynthases, as well as for their applications in biotechnology, is the challenge associated with manipulating the natural microorganism that produces a polyketide of interest. To ameliorate this limitation, over the past decade several genetically amenable microbes have been developed as heterologous hosts for polyketide biosynthesis. Here we review the state of the art as well as the difficulties associated with heterologous polyketide production. In particular, we focus on two model hosts, Streptomyces coelicolor and Escherichia coli. Future directions for this relatively new but growing technological opportunity are also discussed.  相似文献   
238.
The mechanical response under uniaxial compression of collagen discs, made from freeze-dried collagen reconstituted at acid pH, was investigated at 22, 29.5 and 35 degrees C. The pH during compression was maintained at the physiological level of 7.4. The fluid transport model developed by Bert (1970) was fitted to the data. Assumptions, made in the development of the model, were tested and the range of reliability of the model is discussed. The two fitting parameters of the model were found to be stronger functions of hydration than was previously reported. The compressive response of collagen was found to be only weakly influenced by temperature. At 35 degrees C there was evidence of thermal degradation. Some creep was noted at times greater than five half-times, but no attempt was made to quantify it.  相似文献   
239.
240.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号